Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals

3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals

US Patent 9751858 · Granted Sep 5, 2017

Estimated economic value: $7,330,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Azetidine compounds as GPR119 modulators for the treatment of diabetes, obesity,2019
Method for loading executable program instructions into a chip card during activ2019
Isoindolinone compounds as GPR119 modulators for the treatment of diabetes, obes2018
Substituted indanone compounds as GPR119 modulators for the treatment of diabete2018
Fused pyrroledicarboxamides and their use as pharmaceuticals2018
Substituted fused heterocycles as GPR119 modulators for the treatment of diabete2017
Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIa2017
Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-C]pyridines, their use as medicam2017
Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-C]pyridines, their use as medicam2017
Method for generating a certificate2017
Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof2017
Substituted chroman-6-yloxy-cycloalkanes and their use as pharmaceuticals2016